Provision of Intermediate Minor Oral Surgery (IMOS) including treatment under Conscious Sedation across the East Midlands

Descriptions

NHS Nottingham & Nottinghamshire Integrated Care Board (referred to as the Commissioner) is inviting suitably qualified and experienced providers to deliverer 17 Intermediate Minor Oral Surgery (IMOS) Services, including treatment under Conscious Sedation by responding to this opportunity as required and described in this document, and within the published tender.The Commissioner is looking to procure 17 contracts within the following 5 Integrated Care Board’s (ICBs’) locations:1. NHS Derby and Derbyshire ICB2. NHS Nottingham and Nottinghamshire ICB3. NHS Leicester, Leicestershire & Rutland ICB4. NHS Lincolnshire ICB5. NHS Northamptonshire ICBThe specialty of Oral Surgery (OS) deals with the diagnosis and management of pathology of the mouth and jaws that requires surgical intervention. Oral Surgery involves the treatment of children, adolescents and adults, and the management of dentally anxious and/or medically complex patients. Oral Surgery care is provided by Oral Surgeons and by Oral & Maxillofacial Surgeons as the clinical competencies of these two specialties overlap.The service is known/commissioned as Intermediate Minor Oral Surgery (IMOS) including treatment under Conscious Sedation and is aimed at those patients who require Level 2 care – that is ‘procedural and/or patient complexity requiring a clinician with enhanced skills and experience who may or may not be on the specialist register.’The current contracts are due to end on 30th April 2026, the new contracts are expected to commence on 1st May 2026 for a period of 7 years with an option to extend for up to a further 3 years (total contract duration 10 years) under Personal Dental Services Agreements.The total value across all 17 lots per annum is £6,831,310.13. The total 10 year value for all 17 lots is £68,313,101.30Please note the deadline for responses to the Competitive Process is 1700hrs on Tuesday 15th July 2025.